AURORA PHARMACEUTICAL Trademark

Trademark Overview


On Tuesday, November 14, 2023, a trademark application was filed for AURORA PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the AURORA PHARMACEUTICAL trademark a serial number of 98268866. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, July 29, 2024. This trademark is owned by Aurora Pharmaceutical, Inc.. The AURORA PHARMACEUTICAL trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of pharmaceuticals
aurora pharmaceutical

General Information


Serial Number98268866
Word MarkAURORA PHARMACEUTICAL
Filing DateTuesday, November 14, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2023
Primary Code040
First Use Anywhere DateSunday, May 31, 2009
First Use In Commerce DateSunday, May 31, 2009

Trademark Owner History


Party NameAurora Pharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorthfield, MN 55057

Trademark Events


Event DateEvent Description
Tuesday, November 14, 2023NEW APPLICATION ENTERED
Friday, June 14, 2024ASSIGNED TO EXAMINER
Sunday, June 30, 2024NON-FINAL ACTION WRITTEN
Thursday, February 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 30, 2024NON-FINAL ACTION E-MAILED
Monday, July 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED